News | Published:

British Empire Cancer Campaign

Nature volume 154, page 636 (18 November 1944) | Download Citation

Subjects

Abstract

AT a recent meeting, the British Empire Cancer Campaign allocated a sum of £39,000 for the continuation of cancer research during the calendar year 1945. This sum compares with grants totalling nearly £36,000 for the present year. The principal grants are as follows: £10,613 to the Royal Cancer Hospital (Free), including the Chester Beatty Research Institute; £8,000 to the Middlesex Hospital; £3,500 to St. Bartholomew's Hospital; £1,800 to the London Hospital; £2,743 to Mount Vernon Hospital and the Radium Institute; £850 to St. Mark's Hospital, City Road; £1,100 to the Marie Curie Hospital; £120 to the Bristol University Cancer Research Committee; £2,300 to the Cambridge University Cancer Research Centre; £1,740 to the Oxford University Cancer Research Centre; £1,125 to Westminster Hospital; and £5,165 for the expenses of cancer research at the Glasgow Royal Cancer Hospital, University of Glasgow, Institute of Animal Genetics of the University of Edinburgh, University College, Nottingham and St. Thomas's Hospital. These grants are additional to independent expenditure on cancer research by the autonomous branches of the British Empire Cancer Campaign in Birmingham, Yorkshire, Lancashire, Cheshire, North Wales, Northumberland, Cumberland and Durham. These grants are additional to independent expenditure on cancer research by the autonomous branches of the British Empire Cancer Campaign in Birmingham, Yorkshire, Lancashire, Cheshire, North Wales, Northumberland, Cumberland and Durham.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/154636a0

Authors

    Comments

    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing